**Core Concept:** Hepatitis B is an infectious disease caused by the hepatitis B virus (HBV) that primarily affects the liver. It can lead to acute hepatitis, chronic hepatitis, liver cirrhosis, and liver cancer. Acute hepatitis B presents with symptoms like loss of appetite, nausea, vomiting, and fatigue. Serum biochemistry can reveal elevated liver enzymes, particularly alanine transaminase (ALT) and aspartate transaminase (AST).

**Why the Correct Answer is Right:** The correct answer, D, is cirrhosis, because hepatitis B can cause acute or chronic liver inflammation. In severe cases, chronic hepatitis B can lead to progressive liver damage, ultimately resulting in liver cirrhosis. Cirrhosis is characterized by the formation of fibrous tissue scarring in the liver, replacing functional liver tissue. This can lead to organ failure and increased risk for liver-related complications like liver cancer (hepatocellular carcinoma).

**Why Each Wrong Option is Incorrect:**

A. Liver failure: Although hepatitis B can lead to liver dysfunction, the question specifically mentions the patient is "icteric" (yellow due to elevated bilirubin levels) after 2 weeks, indicating liver damage but not failure.

B. Liver cancer: While hepatitis B is a risk factor for liver cancer (hepatocellular carcinoma), the patient is described as icteric after 2 weeks, suggesting liver damage rather than cancer progression.

C. Liver abscess: Hepatitis B is not directly related to liver abscess formation. The symptoms and timeline described are more consistent with liver inflammation and dysfunction, not an abscess.

**Clinical Pearl:** Regular screening for hepatitis B, particularly in high-risk populations, is crucial to detect and manage potential complications promptly. Early intervention can prevent progression to liver cirrhosis and liver cancer. If diagnosed with hepatitis B, patients should be advised to avoid alcohol intake, as it can worsen liver damage. Treatment options include antiviral therapy, which can slow down liver fibrosis progression and reduce the risk of liver-related complications.